Target intelligence / Profile preview

MIR34B and MIR34C host gene (MIR34BHG)

Target
MIR34BHG
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

MIR34BHG, also known as the MIR34B and MIR34C host gene, is a long non-coding RNA (lncRNA) transcribed adjacent to the microRNA miR-34b/c cluster. It is also called SPARCLE (suicidal PARP-1 cleavage enhancer). MIR34BHG/SPARCLE is induced by p53 after DNA damage and functions to enhance apoptosis by acting as a cofactor for caspase-3–mediated cleavage of PARP-1, a protein critical for DNA repair. By facilitating PARP-1 cleavage, MIR34BHG disrupts DNA-damage repair processes and promotes cell death in response to genotoxic stress. This activity is essential for effective p53-mediated tumor suppression and apoptosis. The gene is classified as a lncRNA and lacks a protein-coding function. Current data does not designate MIR34BHG as a traditional drug target or receptor, and there are no known direct interacting drugs or established clinical indications beyond its emerging role in apoptosis and potential links to cancer biology[1][2][3].

Other names
SPARCLEsuicidal PARP-1 cleavage enhancer
02

Mechanism of action

Enhances p53-induced apoptosis by promoting caspase-3–dependent PARP-1 cleavage, leading to inhibition of DNA repair and increased cell death after genotoxic stress

03

Biological functions

ApoptosisDNA damage responsep53-mediated cell death regulationPost-transcriptional gene silencing (miRNA-mediated)Acts as a cofactor for caspase-3–mediated cleavage of PARP-1Regulation of DNA repair
04

Disease associations

Cancer (through p53 pathway and apoptosis)Other roles possible but not well-established
05

Safety considerations

Not established as a direct therapeutic target, so no specific safety concerns are reported
06

Biomarkers

May serve as a biomarker for p53 function or DNA damage–induced apoptosis, but specific clinical biomarker use is not established

Beyond the preview

Go deeper on MIR34B and MIR34C host gene (MIR34BHG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIR34B and MIR34C host gene (MIR34BHG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call